Invitae publishes its Environmental, Social and Governance (ESG) report

– Report describes the company’s commitment to improving healthcare through the power of genetic information and unveils environmental, social and governance initiatives for fiscal year 2023 –

SAN FRANCISCO, April 22, 2024 /PRNewswire/ — To invite (OTC: NVTA), a leading medical genetics company, today published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a holistic view of the company’s ESG approach and its performance and progress through measurable data and metrics during fiscal year 2023.

“At Invitae, sustainability is not just a function; it is woven into the fabric of our DNA. We have embraced sustainability and ESG as catalysts for transformative change,” said Erik Keizerhead of sustainability To invite. “Throughout this journey, our unwavering commitment to our patients and customers remains paramount, ensuring our actions have a positive impact on healthcare, the environment and society.”

The report provides an in-depth overview of the progress made through company-wide ESG initiatives over the past year. The company’s notable achievements include:

• Expand patient access and partnerships: We have focused our efforts on increasing access to genetic testing, resulting in policies, programs and guidelines that now make more patients and their families eligible for testing. Since our founding, we have proudly served more than 4.6 million patients and in 2023 we expanded our rare disease and data partnerships to advance drug discovery.
• Promoting genetic insights: We have strengthened our industry-leading variant classification, Invitae Generation™ capabilities, through advanced technologies such as machine learning and functional modeling. Since 2020, we have seen a 40% reduction in uncertainty thanks to Invitae Generation™ technology. These tools allow us to continue to improve the accuracy of our genetic insights.
• Standard of quality: We have obtained market authorization from the United States (US) Food and Drug Administration (FDA) for one of our hereditary germline cancer panels, a testament to our rigorous standards and product quality. Our hereditary cancer panels provide patients and their families with essential information for informed healthcare decisions.
• Environmental sustainability: We have made progress in managing greenhouse gas emissions in scope 1 and 2, and we have assessed the relevance of the different categories in scope 3 in our value chain. We have also adopted an environmental policy at board level. Environmental sustainability is at the core of our ESG journey.

“I extend my sincere gratitude to our exceptional team members for their dedication, hard work and focus on our patients and on our greater mission: bringing genetic information into mainstream medicine and creating a healthier future for all,” said Ken Knightpresident and general manager of To invite. “I hope you share my enthusiasm for better healthcare through genetic testing, for a better future for our planet and for the well-being of its people. Together we will continue to have a profound impact on healthcare and the world around us .”

Invitations The full 2024 ESG report is available for download here.

About To invite
To invite (OTC: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We strive to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitations genetics experts take a rigorous approach to data and research that is the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

Visit for more information invite.com and follow for updates on LinkedIn, X, InstagramAnd Facebook @Invitation.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s ESG and sustainability plans and initiatives and their expected impact. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered indicative of future performance. These risks and uncertainties include, but are not limited to: risks and uncertainties relating to the Company’s ability to successfully implement and complete a plan of reorganization under Chapter 11; the company’s ability to continue operating in the normal manner while Chapter 11 proceedings are pending; potential adverse effects of the Chapter 11 proceedings on the Company’s business, financial condition, liquidity and results of operations; the Company’s ability to use rapidly changing genetic data to accurately and consistently interpret test results; risks associated with litigation; security breaches, data loss and other disruptions; laws and regulations applicable to the company’s activities; and the other risks set forth in the Company’s filings with the Securities and Exchange Commissionincluding the risks set forth in the Company’s Quarterly Report on Form 10-Q for the most recent quarter September 30, 2023. These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.

Invitation PR contact:
Amy Sands Haddock(email protected)

View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-publishes-its-environmental-social-and-governance-esg-report-302123530.html

SOURCE Invitae Corporation